SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007;369:137990.
  • 2
    Boonen A, Mau W. The economic burden of disease: comparison between rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 2009;27 Suppl:S1127.
  • 3
    Brouwer WB, Koopmanschap MA, Rutten FF. Productivity losses without absence: measurement validation and empirical evidence. Health Policy 1999;48:1327.
  • 4
    Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wan S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting US employers. J Occup Environ Med 2004;46:398412.
  • 5
    Kessler RC, Maclean JR, Petukhova M, Sarawate CA, Short L, Li TT, et al. The effects of rheumatoid arthritis on labor force participation, work performance, and healthcare costs in two workplace samples. J Occup Environ Med 2008;50:8898.
  • 6
    Beaton D, Bombardier C, Escorpizo R, Zhang W, Lacaille D, Boonen A, et al. Measuring worker productivity: frameworks and measures. J Rheumatol 2009;36:21009.
  • 7
    Schultz AB, Chen CY, Edington DW. The cost and impact of health conditions on presenteeism to employers: a review of the literature. Pharmacoeconomics 2009;27:36578.
  • 8
    Escorpizo R, Bombardier C, Boonen A, Hazes JM, Lacaille D, Strand V, et al. Worker productivity outcome measures in arthritis. J Rheumatol 2007;34:137280.
  • 9
    Lerner D, Amick BC III, Rogers WH, Malspeis S, Bungay K, Cynn D. The Work Limitations Questionnaire. Med Care 2001;39:7285.
  • 10
    Boonen A, Brinkhuizen T, Landewe R, van der Heijde D, Severens JL. Impact of ankylosing spondylitis on sick leave, presenteeism and unpaid productivity, and estimation of the societal cost. Ann Rheum Dis 2010;69:11238.
  • 11
    Maksymowych WP, Gooch KL, Wong RL, Kupper H, van der Heijde D. Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis. J Rheumatol 2010;37:38592.
  • 12
    Reilly MC, Gooch KL, Wong RL, Kupper H, van der Heijde D. Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis. Rheumatology (Oxford) 2010;49:8129.
  • 13
    Rohekar S, Pope J. Assessment of work disability in seronegative spondyloarthritis. Clin Exp Rheumatol 2010;28:3540.
  • 14
    Healey EL, Haywood KL, Jordan KP, Garratt A, Packham JC. Impact of ankylosing spondylitis on work in patients across the UK. Scand J Rheumatol 2011;40:3440.
  • 15
    Van der Burg LR, Ter Wee MM,Boonen A. Effect of biological therapy on work participation in patients with ankylosing spondylitis: a systematic review. Ann Rheum Dis 2012;71:192433.
  • 16
    Allen H. Using routinely collected data to augment the management of health and productivity loss. J Occup Environ Med 2008;50:61532.
  • 17
    Janssens H, Clays E, De Clercq B, De Bacquer D, Braeckman L. The relation between presenteeism and different types of future sickness absence. J Occup Health 2013;55:13241.
  • 18
    Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27:3618.
  • 19
    DeVellis RF, Callahan LF. A brief measure of helplessness in rheumatic disease: the helplessness subscale of the Rheumatology Attitudes Index. J Rheumatol 1993;20:8669.
  • 20
    Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M. Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?Rheumatology (Oxford) 1999;38:87882.
  • 21
    Calin A, Jones SD, Garrett SL, Kennedy LG. Bath Ankylosing Spondylitis Functional Index [letter].Br J Rheumatol 1995;34:7934.
  • 22
    Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003;62:206.
  • 23
    Vuong QH. Likelihood ratio tests for model selection and non-nested hypotheses. Econometrica 1989;57:30733.
  • 24
    Long JS, Freese J.Regression models for categorical dependent variables using Stata, second edition.College Station (TX):Stata Press;2006.
  • 25
    Afifi AA, Kotlerman JB, Ettner SL, Cowan M. Methods for improving regression analysis for skewed continuous or counted responses. Annu Rev Public Health 2007;28:95111.
  • 26
    StataCorp.Stata statistical software: release 12.College Station (TX):StataCorp LP;2011.
  • 27
    Cameron AC, Trivedi PK.Microeconometrics using Stata.College Station (TX):Stata Press;2010.
  • 28
    Mihaylova B, Briggs A, O'Hagan A, Thompson SG. Review of statistical methods for analysing healthcare resources and costs. Health Econ 2011;20:897916.
  • 29
    Niedhammer I, Chastang JF, Sultan-Taieb H, Vermeylen G, Parent-Thirion A. Psychosocial work factors and sickness absence in 31 countries in Europe. Eur J Public Health 2013;23:6229.
  • 30
    Bierla I, Huver B, Richard S. New evidence on absenteeism and presenteeism. Int J Hum Resour Manage 2013;24:153650.
  • 31
    Verstappen SM, Fautrel B, Dadoun S, Symmons DP, Boonen A. Methodological issues when measuring paid productivity loss in patients with arthritis using biologic therapies: an overview of the literature. Rheumatology (Oxford) 2012;51:21629.
  • 32
    Taimela S, Laara E, Malmivaara A, Tiekso J, Sintonen H, Justen S, et al. Self-reported health problems and sickness absence in different age groups predominantly engaged in physical work. Occup Environ Med 2007;64:73946.
  • 33
    Brionez TF, Assassi S, Reveille JD, Green C, Learch T, Diekman L, et al. Psychological correlates of self-reported disease activity in ankylosing spondylitis. J Rheumatol 2010;37:82934.
  • 34
    Brionez TF, Assassi S, Reveille JD, Learch TJ, Diekman L, Ward MM, et al. Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis. Arthritis Res Ther 2009;11:R182.
  • 35
    Maksymowych WP, Richardson R, Mallon C, van der Heijde D, Boonen A. Evaluation and validation of the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis. Arthritis Rheum 2007;57:1339.
  • 36
    Gordeev VS, Maksymowych WP, Evers SM, Ament A, Schachna L, Boonen A. Role of contextual factors in health-related quality of life in ankylosing spondylitis. Ann Rheum Dis 2010;69:10812.
  • 37
    Jang JH, Green CE, Assassi S, Reveille JD, Ward MM, Weisman MH, et al. The contribution of disease activity on functional limitations over time through psychological mediators: a 12-month longitudinal study in patients with ankylosing spondylitis. Rheumatology (Oxford) 2011;50:208792.
  • 38
    Savelkoul M, de Witte L, Post M. Stimulating active coping in patients with rheumatic diseases: a systematic review of controlled group intervention studies. Patient Educ Couns 2003;50:13343.